Received Apr 27, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Nurse administered only the men b component of Penmenvy; Nurse administered only the men b component of Penmenvy; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 16-year-old patient who received Men ABCWY NVS (Penmenvy) for prophylaxis. On 09-APR-2026, the patient received the 1st dose of Penmenvy. On 09-APR-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Nurse administered only the men b component of Penmenvy) and inappropriate dose of vaccine administered (Verbatim: Nurse administered only the men b component of Penmenvy). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date; 15-APR-2026 The nurse administered only the men b component of Penmenvy. The reporter consented to follow up. The batch number was not provided upon follow- up with the reporter.